Woodward Stock News

Woodward (NASDAQ:WWD) released its quarterly earnings data on Thursday. The technology company reported $0.82 earnings per share (EPS) for the quarter, missing the Thomson Reuters consensus estimate of $0.86 by ($0.04), MarketWatch Earnings reports. The firm had revenue of $570.00 million for the quarter, compared to analyst estimates of $596.76 million. Woodward had a return []

Weak industrial segment sales, regional market volatility, and supply chain disruptions hurt Woodward's (WWD) fourth-quarter fiscal 2021 earnings.

Weak industrial segment sales, regional market volatility, and supply chain disruptions hurt Woodward's (WWD) fourth-quarter fiscal 2021 earnings.

WWD earnings call for the period ending September 30, 2021.

WWD earnings call for the period ending September 30, 2021.

Woodward (WWD) delivered earnings and revenue surprises of -3.53% and 4.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Woodward, Inc. (WWD) CEO Tom Gendron on Q4 2021 Results - Earnings Call Transcript

FORT COLLINS, Colo., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Woodward, Inc. (NASDAQ:WWD) today reported financial results for its fiscal year 2021 and fourth quarter ending September 30, 2021.

Woodward (WWD) delivered earnings and revenue surprises of -3.53% and 4.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Woodward (NASDAQ:WWD) reported its Q4 earnings results on Thursday, November 18, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

PRINCETON, N.J., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Woodward Pharma Services LLC, a Michigan-based specialty pharmaceutical company, today announced a partnership with Indegene, a technology-led healthcare solutions provider for the support of AcipHex ® (rabeprazole sodium delayed-release tablets). AcipHex ® is a proton-pump inhibitor (PPI) that works by reducing gastric acid secretion and is indicated for the treatment of gastroesophageal reflux disease (GERD), which affects up to 20% of adults in the United States. It is also used to treat duodenal ulcers, and in combination with antibiotics, to treat Helicobacter pylori (H. pylori), a bacterial infection in the stomach. Woodward selected Indegene for its deep healthcare expertise, its flexible and capital-efficient commercial model, and its centers of excellence that have proven to deliver meaningful outcomes. Woodward will leverage Indegene''s advanced omnichannel capabilities, powered by advanced artificial intelligence and machine learning to improve product awareness and

Millennium Management LLC lowered its stake in Woodward, Inc. (NASDAQ:WWD) by 54.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 73,580 shares of the technology company’s stock after selling 87,686 shares during the quarter. Millennium Management LLC’s holdings in Woodward were worth […]

Millennium Management LLC lessened its holdings in shares of Woodward, Inc. (NASDAQ:WWD) by 54.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 73,580 shares of the technology company’s stock after selling 87,686 shares during the quarter. Millennium Management LLC’s […]